BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

Bridgefront Capital, LLC's Holding History (CIK: 0001725690)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025

Shares 23,650 Value ($000) $180 Avg Close $8.33 Range $7.42 - $9.23

Q2 2025

Shares 42,979 Value ($000) $385 Avg Close $9.31 Range $6.02 - $11.31

Q3 2024

Shares 33,126 Value ($000) $252 Avg Close $7.60 Range $6.17 - $8.88

Q2 2024

Shares 12,914 Value ($000) $80 Avg Close $5.52 Range $4.03 - $6.99

Q3 2023

Shares 16,323 Value ($000) $116 Avg Close $7.18 Range $6.62 - $7.95

Q2 2023

Shares 20,302 Value ($000) $143 Avg Close $8.02 Range $6.87 - $9.07

Q1 2021

Shares 20,028 Value ($000) $204 Avg Close $10.31 Range $7.27 - $14.24

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2025	23,650	$180	$8.33	$7.42 - $9.23
Q2 2025	42,979	$385	$9.31	$6.02 - $11.31
Q3 2024	33,126	$252	$7.60	$6.17 - $8.88
Q2 2024	12,914	$80	$5.52	$4.03 - $6.99
Q3 2023	16,323	$116	$7.18	$6.62 - $7.95
Q2 2023	20,302	$143	$8.02	$6.87 - $9.07
Q1 2021	20,028	$204	$10.31	$7.27 - $14.24